Document ID: EPA-HQ-ORD-2006-0187-0132
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2006-04-17T04:00Z

Human
Studies
Review
Board
Meeting
April
3­
6,
2006
Index
of
Public
Commenter
Presentations
April
3,
2006
Alicia
Carriquiry*
HSRB
Board
Member
Notes:
April
3,
2006
Secondary
discussion
 
Aldicarb
MRID
42373001
and
MRID
46131001
April
4,
2006
Celia
B.
Fisher,
Ph.
D.*
Chair
HSRB
PowerPoint
Presentation:
EPA
Human
Studies
Review
Board
 
Chair's
Comments
Alicia
Carriquiry*
HSRB
Board
Member
Notes:
April
4,
2006
Secondary
discussion
 
Aldicarb
MRID
42373001
and
MRID
46131001
Angus
Cameron
From
1985
to
Feb
2002:
Regulatory
Affairs
Manager
at
Inveresk
Research,
Tranent,
Scotland
PowerPoint
Presentation
(
2):
Conduct
of
Human
Volunteer
Studies:
Ethics
&
Methodologies
Dr.
Neil
Carmichael
Global
Head
of
Toxicology
Bayer
CropScience
PowerPoint
Presentation:
Aldicarb
Human
Volunteer
Study
Inveresk
Clinical
Research
1991­
1992
Jennifer
Sass,
Ph.
D.
Natural
Resources
Defense
Council,
Public
Health
Program
PowerPoint
Presentation:
NRDC
comments
for
the
HSRB
meeting
April
4­
6,
2006
Article:
"
Industry
Testing
of
Toxic
Pesticides
on
Human
Subjects
Concluded
`
No
Effect,'
Despite
the
Evidence."
Environmental
Health
Perspectives.
Volume
112,
Number
3.
March
2004.
150­
156.
"
Testing
Toxic
Compounds
in
Human
Subjects:
Ethical
Standards
and
Good
Science."
Environmental
Health
Perspectives.
Volume
112,
Number
8.
June
2004.
458­
461.
"
Human
Testing:
Sass
and
Needleman
Respond
to
Industry."
Environmental
Health
Perspectives.
Volume
112,
Number
6.
May
2004.
340­
341.
"
Benefits
and
Risks
of
Pesticide
Testing
on
Humans."
Environmental
Health
Perspectives.
Volume
113,
Number
12.
December
2005.
804­
805.
Memo
April
11,
2003:
To:
Gary
T.
Patterson,
Ph.
D.,
Chief,
Medical
Toxicology
Branch,
Department
of
Pesticide
Regulation.
Subject:
Comments
and
recommendations
on
the
draft
azinphos­
methyl
risk
characterization
document
prepared
by
the
Department
of
Pesticide
Regulation.

April
5,
2006
Laura
M.
Plunkett,
Ph.
D.,
DABT
Integrative
Biostrategies,
LLC
PowerPoint
Presentation:
DDVP
Human
Studies
 
Charge
Question
1.
b.

Robert
J.
Levine,
MD
Professor
of
Medicine;
Lecturer
in
Pharmacology;
Co­
Director
Interdisciplinary
Bioethics
Center
Yale
University
PowerPoint
Presentation:
EPA's
Review
of
DDVP:
Ethical
Considerations
Ian
Chart
Vice
President,
Director
of
Regulatory
Affairs
Amvac
Chemical
Corporation
PowerPoint
Presentation:
Amvac
Overview:
EPA
Human
Studies
Review
Board
Thomas
B.
Starr,
Ph.
D.
TBS
Associates
PowerPoint
Presentation:
The
Human
DDVP
Data
Do
Provide
Sufficient
Scientifically
Sound
Information
to
Warrant
Reduction
of
the
10X
Interspecies
Factor
Monty
Eberhart,
Ph.
D.,
CIH;
Dan
Van
Goethem,
M.
S.,
DABT
Bayer
CropScience
and
Mahktesheim
Agan
(
MANA)
PowerPoint
Presentation:
Comments
on
Azinphos­
methyl
March
6,
2006
Neil
Carmichael
Global
Head
of
Toxicology
Bayer
CropScience
PowerPoint
Presentation:
Ethephon
Human
Volunteer
Studies
*
Not
a
public
commenter
 
HSRB
Board
Members